Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetraspanin 12 pseudogene refers to a genomic region with sequence similarity to the Tetraspanin 12 (TSPAN12) gene, but due to mutations such as frameshifts or premature stop codons, it is not transcribed or translated into a functional protein. Pseudogenes are remnants of gene duplication or retrotransposition events and are considered non-functional. They are distinct from the active, protein-coding TSPAN12 gene (ENSG00000106025), which is a regulator of the Norrin/β-catenin signaling pathway essential for retinal vascular development; however, the pseudogene itself has no known function, therapeutic relevance, or disease association. The target is not a functional protein or therapeutic target, but rather a non-coding, non-protein-producing pseudogene. It should not be selected as a drug discovery or biomarker target. If your pipeline requires protein-coding, functional targets, map requests for this pseudogene to null or flag as incorrect selection. No evidence supports a role for "tetraspanin 12 pseudogene" as a receptor, enzyme, or disease target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetraspanin 12 pseudogene.